{"id":10738,"date":"2025-08-01T11:27:30","date_gmt":"2025-08-01T16:27:30","guid":{"rendered":"https:\/\/ibio.org\/?page_id=10738"},"modified":"2025-08-01T11:28:18","modified_gmt":"2025-08-01T16:28:18","slug":"investment-report","status":"publish","type":"page","link":"https:\/\/ibio.org\/investment-report\/","title":{"rendered":"Illinois Member Investor Portfolio Report"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”Double Impact Text” _builder_version=”4.27.4″ header_2_font=”Noto Serif||||||||” header_2_font_size=”60px” header_2_line_height=”1.4em” header_3_font=”|700||on|||||” header_3_letter_spacing=”8px” header_3_line_height=”1.8em” text_orientation=”center” header_2_font_size_tablet=”30px” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|phone” z_index_tablet=”500″ text_text_shadow_horizontal_length_tablet=”0px” text_text_shadow_vertical_length_tablet=”0px” text_text_shadow_blur_strength_tablet=”1px” link_text_shadow_horizontal_length_tablet=”0px” link_text_shadow_vertical_length_tablet=”0px” link_text_shadow_blur_strength_tablet=”1px” ul_text_shadow_horizontal_length_tablet=”0px” ul_text_shadow_vertical_length_tablet=”0px” ul_text_shadow_blur_strength_tablet=”1px” ol_text_shadow_horizontal_length_tablet=”0px” ol_text_shadow_vertical_length_tablet=”0px” ol_text_shadow_blur_strength_tablet=”1px” quote_text_shadow_horizontal_length_tablet=”0px” quote_text_shadow_vertical_length_tablet=”0px” quote_text_shadow_blur_strength_tablet=”1px” header_text_shadow_horizontal_length_tablet=”0px” header_text_shadow_vertical_length_tablet=”0px” header_text_shadow_blur_strength_tablet=”1px” header_2_text_shadow_horizontal_length_tablet=”0px” header_2_text_shadow_vertical_length_tablet=”0px” header_2_text_shadow_blur_strength_tablet=”1px” header_3_text_shadow_horizontal_length_tablet=”0px” header_3_text_shadow_vertical_length_tablet=”0px” header_3_text_shadow_blur_strength_tablet=”1px” header_4_text_shadow_horizontal_length_tablet=”0px” header_4_text_shadow_vertical_length_tablet=”0px” header_4_text_shadow_blur_strength_tablet=”1px” header_5_text_shadow_horizontal_length_tablet=”0px” header_5_text_shadow_vertical_length_tablet=”0px” header_5_text_shadow_blur_strength_tablet=”1px” header_6_text_shadow_horizontal_length_tablet=”0px” header_6_text_shadow_vertical_length_tablet=”0px” header_6_text_shadow_blur_strength_tablet=”1px” box_shadow_horizontal_tablet=”0px” box_shadow_vertical_tablet=”0px” box_shadow_blur_tablet=”40px” box_shadow_spread_tablet=”0px” saved_tabs=”all” locked=”off” global_colors_info=”{}”]<\/p>\n

2024 Annual Venture Report | Illinois Life Sciences Investment Reaches Record $1.24B\u00a0<\/h2>\n

\u00a0<\/h3>\n

[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

To celebrate the funding and milestone achievements of life science companies across Illinois and elevate the outstanding stories of life-saving innovation in our community, iBIO has produced our inaugural Annual Venture Report. Illinois\u2019 life sciences ecosystem achieved unprecedented growth with $1.24 billion in venture investments across 99 companies, marking the state\u2019s emergence as a premier biotechnology hub. This comprehensive report showcases the remarkable achievements of Illinois-based life sciences companies, from groundbreaking AI-driven drug discovery platforms to innovative treatments for neurodegenerative diseases. With employment in the sector growing 20 times faster than the state\u2019s overall economy and major infrastructure investments transforming Chicago into a top-10 biopharma destination, Illinois is positioned at the forefront of healthcare innovation.<\/p>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Key Statistics<\/strong><\/div>\n
    \n
  • $1.24B Total Investment<\/li>\n
  • 99 Companies Funded<\/li>\n
  • 93,402 Life Sciences Jobs<\/li>\n
  • 20x Growth Rate vs. State Average<\/li>\n<\/ul>\n
    Report Highlights<\/strong><\/div>\n
      \n
    • Comprehensive analysis of 99 Illinois life sciences companies and their funding rounds<\/li>\n
    • Featured success stories including Vanqua Bio\u2019s $45M Series B and Cour Pharmaceuticals\u2019 $105M Series A<\/li>\n
    • Investment trends showing AI\/Software Solutions dominating with 44% of total funding<\/li>\n
    • Infrastructure developments including 2M+ square feet of new lab space<\/li>\n
    • Strategic insights into Illinois\u2019 emergence as a top-10 biopharma hub<\/li>\n<\/ul>\n

      [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/ibio.org\/wp-content\/uploads\/Cover-232×300.png” title_text=”Cover” url=”https:\/\/ibio.org\/wp-content\/uploads\/iBIO-Investor-Report.pdf” url_new_window=”on” align=”center” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_button button_url=”https:\/\/ibio.org\/wp-content\/uploads\/iBIO-Investor-Report.pdf” url_new_window=”on” button_text=”Download the Report” button_alignment=”center” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

      Illinois life sciences ecosystem achieved $1.24 billion in venture investments across 99 companies. Download iBIO\u2019s inaugural Annual Venture Report showcasing breakthrough companies and investment trends.<\/p>\n","protected":false},"author":12,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-10738","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/pages\/10738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/comments?post=10738"}],"version-history":[{"count":13,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/pages\/10738\/revisions"}],"predecessor-version":[{"id":10754,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/pages\/10738\/revisions\/10754"}],"wp:attachment":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media?parent=10738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}